Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009:2009:431980.
doi: 10.1155/2009/431980. Epub 2010 Feb 3.

The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy

Affiliations

The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy

Eric Davidson et al. Exp Diabetes Res. 2009.

Abstract

We demonstrated that inhibition of neutral endopeptidase (NEP), a protease that degrades vaso- and neuroactive peptides, improves vascular and neural function in diabetic animal models. In this study we explored the role of NEP in neuropathy related to either insulin-deficient diabetes or diet-induced obesity using NEP deficient (-/-) mice. Initial studies showed that streptozotocin, in the absence of subsequent hyperglycemia, did not induce nerve conduction slowing or paw thermal hypoalgesia. Glucose disposal was impaired in both C57Bl/6 and NEP -/- mice fed a high fat diet. Thermal hypoalgesia and nerve conduction slowing were present in both streptozotocin-diabetic and high fat fed C57Bl/6 mice but not in NEP -/- mice exposed to either streptozotocin-induced diabetes or a high fat diet. These studies suggest that streptozotocin does not induce neurotoxicity in mice and that NEP plays a role in regulating nerve function in insulin-deficient diabetes and diet-induced obesity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Glucose utilization curve for C57Bl/6 (a) and neutral endopeptidase (NEP −/−) deficient mice (b) fed a normal or high fat containing diet for 12 weeks. Data are the mean ± standard error of the mean. The numbers of animals for each group are indicated in parenthesis. *P < .05 versus control.
Figure 2
Figure 2
Motor and sensory nerve conduction velocity for C57Bl/6 (a) and neutral endopeptidase (NEP −/−) deficient mice (b). Study groups included mice fed a normal diet for 12 weeks (control), streptozotocin-induced diabetes duration 12 weeks, or fed a high fat containing diet for 12 weeks. Data are the mean ± standard error of the mean. The numbers of animals for each group are indicated in parenthesis. *P < .05 versus control, + P < .05 versus C57Bl/6 mice.
Figure 3
Figure 3
Thermal response latency in the hindpaw for C57Bl/6 and neutral endopeptidase (NEP −/−) deficient mice. Study groups included mice fed a normal diet for 12 weeks (control), streptozotocin-induced diabetes duration 12 weeks, or fed a high fat containing diet for 12 weeks. Data are the mean ± standard error of the mean. The numbers of animals for each group are the same as described in Table 1. *P < .05 versus control C57Bl/6, + P < .05 C57Bl/6 mice versus NEP −/− mice, respectively.

Similar articles

Cited by

References

    1. Boulton AJM, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–962. - PubMed
    1. Ziegler D. Treatment of diabetic polyneuropathy update 2006. Annals of the New York Academy of Sciences. 2006;1084:250–266. - PubMed
    1. Tavakoli M, Malik RA. Management of painful diabetic neuropathy. Expert Opinion on Pharmacotherapy. 2008;9(17):2969–2978. - PubMed
    1. Singleton JR, Smith AG. Therapy insight: neurological complications of prediabetes. Nature Clinical Practice Neurology. 2006;2(5):276–282. - PubMed
    1. Smith AG, Singleton JR. Impaired glucose tolerance and neuropathy. Neurologist. 2008;14(1):23–29. - PubMed

Publication types

MeSH terms

LinkOut - more resources